Detection and In Silico Study of Neochlorogenic Acid from Rhizophora apiculata Stem Bark Extract as HBV Replication Inhibitors

Authors

Muhammad Khalil , Yonadiah Dwitya

DOI:

10.29303/jppipa.v9i9.5144

Published:

2023-09-25

Issue:

Vol. 9 No. 9 (2023): September

Keywords:

Hepatitis B Replication, Molecular docking, Neochlorogenic acid, Rhizophora apiculata

Research Articles

Downloads

How to Cite

Khalil, M., & Dwitya, Y. (2023). Detection and In Silico Study of Neochlorogenic Acid from Rhizophora apiculata Stem Bark Extract as HBV Replication Inhibitors. Jurnal Penelitian Pendidikan IPA, 9(9), 7563–7569. https://doi.org/10.29303/jppipa.v9i9.5144
Crossref
Scopus
Google Scholar
Europe PMC

Downloads

Metrics

PDF views
125
Sep 25 '23Sep 28 '23Oct 01 '23Oct 04 '23Oct 07 '23Oct 10 '23Oct 13 '23Oct 16 '23Oct 19 '23Oct 22 '236.0
|

Abstract

This study aims to detect and characterize the presence of neochlorogenic acid in Rhizophora apiculata stem bark extract and to examine its potential as an inhibitor of Hepatitis B virus (HBV) replication with in silico approach. This explorative descriptive study used liquid chromatography-mass spectrometry (LC-MS/MS) analysis to detect the content of neochlorogenic acid, and an in silico study through molecular docking analysis using the blind docking technique to test its potential to inhibit HBV replication. LCMS/MS results showed that the neochlorogenic acid was present in R. apiculata stem bark extract which was detected with a peak at 3.94 retention time, and fragment ion with a m/z value of 355.1029. The docking analysis results showed that neochlorogenic acid forms a binding site that is relatively similar to the reference ligand to the HBV capsid protein, involving amino acid residues PHE 23, PRO 25, PHE 110, TYR 118, TRP 102, ILE 139, LEU 140, and SER 141, with binding affinity score -6.3 kcal/mol. Therefore, based on the results of this study, it can be concluded that neochlorogenic acid derived from stem bark extract of R. apiculata has the potential to be used as an alternative treatment for hepatitis B virus infection. 

References

Agarwal, K., Lok, J., Carey, I., Shivkar, Y., Biermer, M., Berg, T., & Lonjon-Domanec, I. (2022). A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV ‘cure.’ Journal of Hepatology, 77(1), 245–248. https://doi.org/10.1016/j.jhep.2022.03.006

Alsareii, S. A., Manaa Alamri, A., AlAsmari, M. Y., Bawahab, M. A., Mahnashi, M. H., Shaikh, I. A., … Kumbar, V. (2022). Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity. Molecules, 27(19), 6306. https://doi.org/10.3390/molecules27196306

Bitencourt-Ferreira, G., Pintro, V. O., & de Azevedo, W. F. (2019). Docking with AutoDock4. https://doi.org/10.1007/978-1-4939-9752-7_9

Chu, C.-M. (2000). Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. Journal of Gastroenterology and Hepatology, 15(5 (Suppl.)), E25–E30. https://doi.org/10.1046/j.1440-1746.2000.02097.x

Dandri, M. (2020). Epigenetic modulation in chronic hepatitis B virus infection. Seminars in Immunopathology, 42(2), 173–185. https://doi.org/10.1007/s00281-020-00780-6

Fatchur, R., & Putra, W. E. (2020). Short Communication: The bioinformatics perspective of Foeniculum vulgare fruit’s bioactive compounds as natural anti-hyperglycemic against alpha-glucosidase. Biodiversitas Journal of Biological Diversity, 22(1). https://doi.org/10.13057/biodiv/d220111

Fung, J., Lai, C.-L., Seto, W.-K., & Yuen, M.-F. (2011). Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. Journal of Antimicrobial Chemotherapy, 66(12), 2715–2725. https://doi.org/10.1093/jac/dkr388

Gao, X., Zhang, S., Wang, L., Yu, L., Zhao, X., Ni, H., … Fu, Y. (2020). Anti-Inflammatory Effects of Neochlorogenic Acid Extract from Mulberry Leaf (Morus alba L.) Against LPS-Stimulated Inflammatory Response through Mediating the AMPK/Nrf2 Signaling Pathway in A549 Cells. Molecules, 25(6), 1385. https://doi.org/10.3390/molecules25061385

Grasso, G., Di Gregorio, A., Mavkov, B., Piga, D., Labate, G. F. D., Danani, A., & Deriu, M. A. (2022). Fragmented blind docking: a novel protein–ligand binding prediction protocol. Journal of Biomolecular Structure and Dynamics, 40(24), 13472–13481. https://doi.org/10.1080/07391102.2021.1988709

Hu, J., Protzer, U., & Siddiqui, A. (2019). Revisiting Hepatitis B Virus: Challenges of Curative Therapies. Journal of Virology, 93(20). https://doi.org/10.1128/JVI.01032-19

Ismail, S., Waheed, Y., Ahmad, S., Ahsan, O., Abbasi, S. W., & Sadia, K. (2022). An in silico study to unveil potential drugs and vaccine chimera for HBV capsid assembly protein: combined molecular docking and dynamics simulation approach. Journal of Molecular Modeling, 28(2), 51. https://doi.org/10.1007/s00894-022-05042-w

Khalil, M. (2020). The potention of bioactive compound β-carotene as anti-hepatitis B virus candidate. Jurnal Geuthèë: Penelitian Multidisiplin, 3(1), 393. https://doi.org/10.52626/jg.v3i1.73

Khalil, M. (2023). Simulasi Molecular Docking Senyawa Coumestrol dengan Protein Kapsid Virus Hepatitis B: Studi In Silico Potensi Senyawa Alami. Jurnal Jeumpa, 10(1), 138–148. https://doi.org/10.33059/jj.v10i1.7606

Khalil, M., Akbar, M. N., Saputra, A. R., & Kusuma, S. H. (2023). Naringin’s potential as a hepatitis b virus replication inhibitor: an in-silico study of secondary metabolite compound. Jurnal Farmasi Sains Dan Praktis, 9(2), 104–113. https://doi.org/10.31603/pharmacy.v9i2.8564

Khalil, M., Amin, M., & Lukiati, B. (2020). Analisis potensi senyawa repensol sebagai kandidat inhibitor replikasi virus hepatitis B secara in silico. In Prosiding Seminar Nasional Biotik, 8(1), 358–363. https://doi.org/https://doi.org/10.22373/pbio.v8i2.9669.

Khatun, M. S., & Biswas, M. H. A. (2020). Optimal control strategies for preventing hepatitis B infection and reducing chronic liver cirrhosis incidence. Infectious Disease Modelling, 5, 91–110. https://doi.org/10.1016/j.idm.2019.12.006

Lezoul, N. E. H., Belkadi, M., Habibi, F., & Guillén, F. (2020). Extraction Processes with Several Solvents on Total Bioactive Compounds in Different Organs of Three Medicinal Plants. Molecules, 25(20), 4672. https://doi.org/10.3390/molecules25204672

Li, A., Wu, J., Zhai, A., Qian, J., Wang, X., Qaria, M., … Zhang, F. (2019). HBV triggers APOBEC2 expression through miR‑122 regulation and affects the proliferation of liver cancer cells. International Journal of Oncology, 55(5). https://doi.org/10.3892/ijo.2019.4870

Li, W., Deng, R., Liu, S., Wang, K., & Sun, J. (2020). Hepatitis B virusâ€related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of nonâ€viral risk factors. Liver International, 40(10), 2316–2325. https://doi.org/10.1111/liv.14607

Liu, L. (2020). Clinical features of hepatocellular carcinoma with hepatitis B virus among patients on Nucleos(t) ide analog therapy. Infectious Agents and Cancer, 15(1), 8. https://doi.org/10.1186/s13027-020-0277-y

Mitra, S., Naskar, N., & Chaudhuri, P. (2021). A review on potential bioactive phytochemicals for novel therapeutic applications with special emphasis on mangrove species. Phytomedicine Plus, 1(4), 100107. https://doi.org/10.1016/j.phyplu.2021.100107

Morris, C. J., & Corte, D. Della. (2021). Using molecular docking and molecular dynamics to investigate protein-ligand interactions. Modern Physics Letters B, 35(08), 2130002. https://doi.org/10.1142/S0217984921300027

Murata, K., Asano, M., Matsumoto, A., Sugiyama, M., Nishida, N., Tanaka, E., … Mizokami, M. (2018). Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. Gut, 67(2), 362–371. https://doi.org/10.1136/gutjnl-2016-312653

Pley, C. M., McNaughton, A. L., Matthews, P. C., & Lourenço, J. (2021). The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Global Health, 6(1), e004275. https://doi.org/10.1136/bmjgh-2020-004275

Qiu, Z., Lin, X., Zhou, M., Liu, Y., Zhu, W., Chen, W., … Tang, G. (2016). Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors. Journal of Medicinal Chemistry, 59(16), 7651–7666. https://doi.org/10.1021/acs.jmedchem.6b00879

Saroyo, H., & Saputri, N. F. M. (2021). Cytotoxicity of Mangrove Leaves (Rhizophora) Ethanolic Extract on Cancer Cells. Journal of Nutraceuticals and Herbal Medicine, 4(1), 43–52. https://doi.org/10.23917/jnhm.v4i1.15657

Sivaperumal, P., Kamala, K., Sangeetha, V. L., Ganapathy, D. M., & Jeevan Kumar, G. J. (2023). Antioxidant potential from true mangroves and their associated marine organisms. In Marine Antioxidants (pp. 233–240). https://doi.org/10.1016/B978-0-323-95086-2.00017-5

Su, F.-H., Le, T. N., Muo, C.-H., Te, S. A., Sung, F.-C., & Yeh, C.-C. (2020). Chronic Hepatitis B Virus Infection Associated with Increased Colorectal Cancer Risk in Taiwanese Population. Viruses, 12(1), 97. https://doi.org/10.3390/v12010097

Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, NA-NA. https://doi.org/10.1002/jcc.21334

Vinoth, R., Kumaravel, S., & Ranganathan, R. (2019). Therapeutic and Traditional Uses of Mangrove Plants. Journal of Drug Delivery and Therapeutics, 9(4-s), 849–854. https://doi.org/10.22270/jddt.v9i4-s.3457

Wang, G., & Chen, Z. (2022). HBV Genomic Integration and Hepatocellular Carcinoma. Advanced Gut & Microbiome Research, 2022, 1–7. https://doi.org/10.1155/2022/2140886

Yeh, S.-H., Li, C.-L., Lin, Y.-Y., Ho, M.-C., Wang, Y.-C., Tseng, S.-T., & Chen, P.-J. (2023). Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC. Cellular and Molecular Gastroenterology and Hepatology, 15(4), 921–929. https://doi.org/10.1016/j.jcmgh.2023.01.001

Yu, M.-H., Hung, T.-W., Wang, C.-C., Wu, S.-W., Yang, T.-W., Yang, C.-Y., … Wang, C.-J. (2021). Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In Vitro. International Journal of Molecular Sciences, 22(23), 13163. https://doi.org/10.3390/ijms222313163

Author Biographies

Muhammad Khalil, Universitas Samudra

Department of Biology Education, Universitas Samudra, Langsa, Indonesia

Yonadiah Dwitya, Universitas Samudra

Department of Biology, Universitas Samudra, Langsa, Indonesia

License

Copyright (c) 2023 Muhammad Khalil, Yonadiah Dwitya

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).